Clinical Trial Update: Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

A phase 1 clinical trial evaluating the combination of gemcitabine and capecitabine in patients with advanced pancreatic cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Swedish Medical Center | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED